Fremanezumab-Vfrm
Common brands: Ajovy, Topamax, Neurontin, Botox, Vitamin D
Top reporter: Teva Pharmaceuticals Usa, Inc.
Nonsteroidal Anti-inflammatory Drug [EPC]Benzodiazepine [EPC]Acetylcholine Release Inhibitor [EPC]Neuromuscular Blocker [EPC]Provitamin D2 Compound [EPC]
10,985
Total Reports
5,007
Serious Reports
101
Death Reports
30
Reported Reactions
Death Report Ratio: Low (0.92%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Fremanezumab-Vfrm.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | ACCIDENTAL EXPOSURE TO PRODUCT | 1,438 | |
| 2 | INJECTION SITE PAIN | 1,280 | |
| 3 | MIGRAINE | 987 | |
| 4 | DRUG INEFFECTIVE | 888 | |
| 5 | HEADACHE | 720 | |
| 6 | INJECTION SITE ERYTHEMA | 634 | |
| 7 | DEVICE LEAKAGE | 559 | |
| 8 | INJECTION SITE PRURITUS | 483 | |
| 9 | DEVICE MALFUNCTION | 478 | |
| 10 | FATIGUE | 471 | |
| 11 | NAUSEA | 463 | |
| 12 | INJECTION SITE SWELLING | 432 | |
| 13 | DRUG DOSE OMISSION BY DEVICE | 415 | |
| 14 | INCORRECT DOSE ADMINISTERED BY DEVICE | 387 | |
| 15 | DIZZINESS | 375 | |
| 16 | PRODUCT DOSE OMISSION ISSUE | 365 | |
| 17 | PRURITUS | 343 | |
| 18 | INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 325 | |
| 19 | RASH | 306 | |
| 20 | PAIN | 305 | |
| 21 | DEVICE ISSUE | 297 | |
| 22 | CONSTIPATION | 296 | |
| 23 | INJECTION SITE REACTION | 296 | |
| 24 | ALOPECIA | 293 | |
| 25 | ARTHRALGIA | 281 | |
| 26 | NEEDLE ISSUE | 275 | |
| 27 | INCORRECT DOSE ADMINISTERED | 273 | |
| 28 | INJECTION SITE RASH | 271 | |
| 29 | ANXIETY | 264 | |
| 30 | MALAISE | 250 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.